Related Experiment Videos
Alpha-crystallin acting as a molecular chaperone protects catalase against steroid-induced inactivation
1Nuffield Laboratory of Ophthalmology, University of Oxford, Oxford, UK.
Abstract:
A link between corticosteroid therapy and the development of cataract has been known for many years. However, the precise underlying molecular mechanism of pathology has not been characterised, although a role for direct deleterious interactions between corticosteroids and lenticular proteins has been investigated. Alpha-crystallin is a major lens protein that has exhibited chaperone properties in vitro. Catalase is a ubiquitous enzyme that is an important scavenger of hydrogen peroxide in vivo. The corticosteroid prednisolone-21-hemisuccinate was found to inactivate bovine liver catalase, in vitro in a progressive manner. Coincubation of alpha-crystallin with catalase in a 1:2 molar ratio (one alpha-crystallin to two catalase molecules) fully protected against this inactivation. The protection was specific. Aspirin-like analgesics, putative anti-cataract drugs offered no such protection.
Insights
Corticosteroid therapy can cause cataracts. Alpha-crystallin, a lens protein, protected catalase from inactivation by prednisolone, suggesting a potential therapeutic role in preventing corticosteroid-induced cataracts.
Area of Science:
- Biochemistry
- Ophthalmology
- Molecular Biology
Background:
- Corticosteroid therapy is linked to cataract development.
- The molecular mechanisms underlying this pathology remain unclear.
- Investigating direct interactions between corticosteroids and lens proteins is crucial.
Purpose of the Study:
- To investigate the protective role of alpha-crystallin against corticosteroid-induced protein damage.
- To elucidate the molecular mechanism of cataract formation linked to corticosteroid use.
Main Methods:
- In vitro inactivation of bovine liver catalase by prednisolone-21-hemisuccinate.
- Assessing the protective effect of alpha-crystallin during coincubation with catalase.
- Evaluating the specificity of protection against other compounds like aspirin.
Main Results:
- Prednisolone-21-hemisuccinate progressively inactivated catalase in vitro.
- Alpha-crystallin (1:2 molar ratio) fully protected catalase from prednisolone-induced inactivation.
- Aspirin-like analgesics did not offer similar protection, indicating specificity.
Conclusions:
- Alpha-crystallin demonstrates protective chaperone-like properties against corticosteroid-induced damage to catalase.
- This finding suggests a potential therapeutic strategy using alpha-crystallin to mitigate corticosteroid-induced cataracts.
- The protective mechanism appears specific to alpha-crystallin, differentiating it from other potential treatments.